Ultrasound-Guided Stellate Ganglion Block With Botulinum

Assiut University

Status: Completed

Conditions: Change From Baseline House-Brackmann

Treatments: Drug: Botox; Drug: triamcinolonacetonide

Study type: Interventional

Funder types: Other

Identifiers

NCT05099835

000092

Details and patient eligibility

About

the local stellate ganglion block with bupivacaine and corticosteroid treatment for acute peripheral facial nerve palsy in patients can induce hyperglycemia, and an alternative local therapy may be necessary and some time may ve ineffective. Our purpose in this study is to evaluate therapeutic effects of stellate ganglion block (SGB) Botulinum Toxin on referactory facial nerve palsy

Full description

:Idiopathic facial nerve palsy (Bell's palsy) is caused by damage to the facial nerve at any site of the peripheral branches after the facial nucleus.Stellate ganglion block is inteneded to increase blood flow and promotes nerve regeneration. the local stellate ganglion block with bupivacaine and corticosteroid treatment for acute peripheral facial nerve palsy in patients can induce hyperglycemia, and an alternative local therapy may be necessary and some time may ve ineffective. Our purpose in this study is to evaluate therapeutic effects of stellate ganglion block (SGB) Botulinum Toxin on referactory facial nerve palsy

Enrollment: 60 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed by clinical and neurological assessment as one-sided idiopathic facial palsy
• Age 18 to 60 •-ASA i-II

Exclusion criteria

• Exclusion Criteria:

  • diabetic
  • coagulation dysfunction
  • mental or cognitive dysfunclion
  • allergy to injected medication

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

60 participants in 2 patient groups

Botulinum Toxin

Active Comparator group

Description:

injected 10 mL of 0.1% bupivacaine with 100 Botox units (BOTOX®, Allergan Inc., Irvine, CA, USA)

Treatment:

Drug: Botox

steroid

Active Comparator group

Description:

injected 10 mL of 0.25% bupivacaine with triamcinolonacetonide 4 mg/ml

Treatment:

Drug: triamcinolonacetonide